Two Psychedelics Companies Collaborate To Provide Clinical-Grade MDMA Capsules For Authorized Patients And Studies
MDXX-class molecules producer PharmAla Biotech Holdings Inc.
From Shrooms To Stars: The Secret Drug Culture Of ‘Super Mario Bros.’
By Santiago Alonso, via El Planteo.
This Psychiatrist Calls Cannabis Is A Minor-League Psychedelic & Undervalued Investment Opportunity
Cannabis is a psychedelic that belongs to the group of mind-manifesting substances, according to Dr. Julie Holland. "When you get high on cannabis, you can see your thoughts differently, and it can give you a bigger perspective on life," she said in an interview with Rena Sherbill from the Cannabis Investing Podcast.
This Groundbreaking Ketamine Topical Cream Is Capturing Rick Doblin’s Attention
Psycheceutical Bioscience (OTC: BWVI), a company focused on developing innovative technologies for the next generation of mental health treatments, recently hosted Rick Doblin, founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), at one of its drug develop
Psyched: Canada’s Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism
A patient-led lawsuit against the Canadian government is claiming access to therapeutic psilocybin is a constitutional right under the Canadian Charter of Rights and Freedoms.
Therapists At Mass General Hospital Prepared To Assist IBS Patients With Psilocybin Therapy
Psychotherapists at the Massachusetts General Hospital (MGH) have undergone training by lead business Fluence toward participating in Tryp Therapeutics (OTCQB: T
How To Finance A Psychedelics Business? Learn From These Four Companies
Clearmind Medicine Announces Pricing of $3.5 Million Public Offering
Are Psychedelics A Threat To Alcohol And Tobacco Industries? A Glance At Thriving Advances
As the attachment to both tobacco and alcohol is deeply rooted and likely intertwined with other human and societal factors, it is evident these behaviors are complex to analyze.
And yet, the near future seems to hold hope for those ready and willing to disengage from these practices. The formula would include patience, support and psychedelics.
DMT For Major Depression Shows Remarkable Benefits After Six-Month Trial
Short-acting psychedelics company Small Pharma Inc.
Intravenous DMT Therapy Seeks Ideal Dosage For Stroke And TBI Treatment
Canadian biopharma company Algernon Pharmaceuticals Inc.